JP2024040501A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024040501A5 JP2024040501A5 JP2024021635A JP2024021635A JP2024040501A5 JP 2024040501 A5 JP2024040501 A5 JP 2024040501A5 JP 2024021635 A JP2024021635 A JP 2024021635A JP 2024021635 A JP2024021635 A JP 2024021635A JP 2024040501 A5 JP2024040501 A5 JP 2024040501A5
- Authority
- JP
- Japan
- Prior art keywords
- film
- layer containing
- tablet according
- coated tablet
- coated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- 239000007941 film coated tablet Substances 0.000 claims 6
- 239000003826 tablet Substances 0.000 claims 4
- 239000005485 Azilsartan Substances 0.000 claims 3
- 239000000654 additive Substances 0.000 claims 3
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 claims 3
- 229960004005 amlodipine besylate Drugs 0.000 claims 3
- KGSXMPPBFPAXLY-UHFFFAOYSA-N azilsartan Chemical compound CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C1=NOC(=O)N1 KGSXMPPBFPAXLY-UHFFFAOYSA-N 0.000 claims 3
- 229960002731 azilsartan Drugs 0.000 claims 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 2
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 235000013772 propylene glycol Nutrition 0.000 claims 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims 1
- 239000001069 triethyl citrate Substances 0.000 claims 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims 1
- 235000013769 triethyl citrate Nutrition 0.000 claims 1
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2024021635A JP2024040501A (en) | 2020-03-31 | 2024-02-16 | Film-coated tablets containing azilsartan and amlodipine besylate |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020073113A JP7441105B2 (en) | 2020-03-31 | 2020-03-31 | Film-coated tablets containing azilsartan and amlodipine besilate |
JP2024021635A JP2024040501A (en) | 2020-03-31 | 2024-02-16 | Film-coated tablets containing azilsartan and amlodipine besylate |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020073113A Division JP7441105B2 (en) | 2020-03-31 | 2020-03-31 | Film-coated tablets containing azilsartan and amlodipine besilate |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2024040501A JP2024040501A (en) | 2024-03-25 |
JP2024040501A5 true JP2024040501A5 (en) | 2024-04-01 |
Family
ID=78002503
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020073113A Active JP7441105B2 (en) | 2020-03-31 | 2020-03-31 | Film-coated tablets containing azilsartan and amlodipine besilate |
JP2024021635A Withdrawn JP2024040501A (en) | 2020-03-31 | 2024-02-16 | Film-coated tablets containing azilsartan and amlodipine besylate |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020073113A Active JP7441105B2 (en) | 2020-03-31 | 2020-03-31 | Film-coated tablets containing azilsartan and amlodipine besilate |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP7441105B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116440132A (en) * | 2022-12-20 | 2023-07-18 | 福建瑞泰来医药科技有限公司 | Medicament containing amlodipine and azilsartan and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4972563B2 (en) | 2006-01-20 | 2012-07-11 | 大日本住友製薬株式会社 | New film-coated tablets |
WO2010126168A2 (en) | 2009-04-30 | 2010-11-04 | Takeda Pharmaceutical Company Limited | Solid preparation |
JP2015013857A (en) | 2013-06-06 | 2015-01-22 | 武田薬品工業株式会社 | Coated formulation |
CA3019499A1 (en) | 2016-03-31 | 2017-10-05 | Intercept Pharmaceuticals, Inc. | Film-coated tablet having high chemical stability of active ingredient |
JP2019001782A (en) | 2017-06-14 | 2019-01-10 | 東和薬品株式会社 | Bilayer tablet |
JP7271869B2 (en) | 2018-07-25 | 2023-05-12 | ニプロ株式会社 | Tablets containing levocetirizine |
-
2020
- 2020-03-31 JP JP2020073113A patent/JP7441105B2/en active Active
-
2024
- 2024-02-16 JP JP2024021635A patent/JP2024040501A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2024040501A5 (en) | ||
JP5173794B2 (en) | SRC / ABL inhibitor | |
JP2019151657A5 (en) | ||
JP2005320354A5 (en) | ||
JPS63161953A (en) | Denture stabilizer composition | |
JPWO2008129730A1 (en) | Method for producing orally administered drug | |
KR20080008362A (en) | Film coated preparation containing dextrose | |
TW201414508A (en) | Pharmaceutical administration forms comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide | |
JP5047572B2 (en) | Method for producing solid pharmaceutical preparation with odor prevention, and solid pharmaceutical preparation obtained thereby | |
JP2016518405A (en) | Donepezil free base-containing film preparation and method for producing the same | |
JP5454162B2 (en) | Film-coated solid preparation containing sublimable component | |
GB1355324A (en) | Enteric medicaments | |
KR102149020B1 (en) | Film-coated tablet having high damp proof property | |
KR101998288B1 (en) | Composition for smokeless tobacco and orally dissolving film-type smokeless tobacco comprising the same | |
SA04250370A (en) | Method and compositions for selecctin inhibition | |
KR20120086689A (en) | Film-coated tablet which is suppressed in discoloration and odor | |
WO2006062077A1 (en) | Film coating composition, coating film thereof, and tablet | |
JP2017206488A (en) | Gefitinib tablet and method for producing gefitinib tablet | |
JP7000148B2 (en) | A pharmaceutical composition containing dasatinib as an active ingredient | |
JP6059805B2 (en) | Coating agent containing hydroxyalkyl cellulose | |
JP2020033282A (en) | Method for producing solid pharmaceutical composition | |
JP2006256975A (en) | Guaifenesin-containing preparation | |
George et al. | Population pharmacokinetics of ripretinib in patients with advanced malignancies | |
Rewell | Haemangiopericytoma of the gum | |
CN102475690A (en) | Alfuzosin hydrochloride-containing slow-release tablets |